search
Back to results

Natural Versus Synthetic Vitamin B Complexes in Human

Primary Purpose

Healthy, Thiamine and Niacin Deficiency States, Pyridoxine Deficiency

Status
Completed
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Natural Panmol-B-Complex
Synthetic Vitamin B-Complex
Sponsored by
Medical University of Graz
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Healthy

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Male and female
  • 18-65 y
  • Healthy

Exclusion Criteria:

  • Cholesterol >240mg/dl
  • Study inclusion in the past 2 months
  • Pregnancy and lactation period
  • Clinical diagnosis of chronic infections
  • Ingestion of trace elements, vitamin- and fatty acid supplements in the past 3 months
  • Clinical diagnosis of cardiovascular disease
  • Clinical diagnosis of cancer
  • Clinical diagnosis of psychotic diseases
  • Insulin dependent diabetes
  • Clinical diagnosis of autoimmune diseases
  • Maldigestion/Malabsorption
  • Veganes cuisine
  • > 1 Beer/day

Sites / Locations

  • Wonisch Willibald

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Natural Panmol-B-Complex first, then synthetic Vitamin B-complex

Synthetic Vitamin B-complex first, then Natural Panmol-B-Complex

Arm Description

Participants first received a Natural Vitamin B-complex, i.e., Panmol-B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.

Participants first received a Synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a natural Vitamin B-complex, i.e., Panmol-B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.

Outcomes

Primary Outcome Measures

Serum Thiamine
Serum Thiamine in microgram per liter Minimum: 36 Maximum: 98
Serum Riboflavin
Serum Riboflavin in microgram per liter Minimum: 190 Maximum: 341
Serum Pyridoxine
Serum Pyridoxine in microgram per liter Minimum: 3.8 Maximum: 161.8
Serum Folic Acid
Serum Folic acid in nanogram per liter Minimum: 2.20 Maximum: 58.10
Serum Cobalamin
Serum Cobalamin in picogram per liter Minimum: 159 Maximum: 1230

Secondary Outcome Measures

Serum Total Peroxides
Serum Total peroxides in micromol per liter Minimum: 23 Maximum: 443
Serum Total Antioxidant Capacity
Serum total antioxidant capacity in millimole per liter Minimum: 0.31 Maximum: 2.45
Serum Endogenous Peroxidase-activity
Serum endogenous peroxidase-activity in milliunits per milliliter Minimum: 0.79 Maximum: 9.87
Serum Polyphenols
Serum Polyphenols in millimole per liter Minimum: 7.45 Maximum: 10.91
Total Homocysteine
Total Homocysteine in Micromole Minimum: 4.00 Maximum: 40.40

Full Information

First Posted
January 8, 2018
Last Updated
April 23, 2021
Sponsor
Medical University of Graz
search

1. Study Identification

Unique Protocol Identification Number
NCT03444155
Brief Title
Natural Versus Synthetic Vitamin B Complexes in Human
Official Title
Pilot Study for the Evaluation of the Effectiveness of Natural Versus Synthetic Vitamin B Complexes in Humans.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
May 8, 2017 (Actual)
Primary Completion Date
October 3, 2017 (Actual)
Study Completion Date
November 17, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medical University of Graz

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
In a cross-over study the investigators evaluate the effects of natural (Panmol-B-Complex) (Pan [Greek] = all; moles [Latin] = molecules/particles - brand name) versus synthetic vitamin B complexes to identify the bioavailability of distinct vitamins as well as long-term effects. The primary hypothesis for this study: "Natural Vitamin B-complexes are as effective as synthetic Vitamin B-complexes or better." For this reason 30 subjects (18 to 65y; BMI >19 to <29) were recruited for this study. The study population was divided into 2 groups of each 15 subjects in a cross-over trial. Vitamin supplementation consisted of Thiamine (2.93 mg), Riboflavin (3.98 mg), Niacin (29.85 mg), Pantothenic acid (10.95 mg), Pyridoxine (3.38 mg), Biotin (0.108 mg), Folic acid (0.69 mg) and Cobalamin (8.85 µg) per day in both groups. Blood samples are taken at baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - wash out phase I (2 weeks); start cross-over: baseline - 1.5h after vitamin supplementation - 4h - 7h - 6 weeks - washout phase II (6 weeks). In case of main target criteria Thiamin, Riboflavin, Pyridoxine, Folic acid and Cobalamin were measured in serum as well as total peroxides (µmol/L), peroxidase-activity (U/L), total antioxidant status (mmol/L) and polyphenols (mmol/L).
Detailed Description
Design: Monocentric double-blind experiment Scientific background: Vitamin B-complex is water-soluble and essential for humans. Vitamin B deficiency is associated with neurologic diseases, heart insufficiency, diminished hormone production and maldigestion. Due to the fact that literature search did not reveal distinct information about natural versus synthetic Vitamin B-complexes this study was initiated to investigate bioavailability and long-term effects of natural Vitamin B-complexes in comparison to synthetic Vitamin B-complexes. Vitamin B complex was filled in hydroxypropylmethylcellulose capsules (size 0, ivory-coloured). Daily dose = 3 capsules in the morning with 250ml water. Blinding/Randomization: The person in charge for manufacturing and blinding arranged an identical packaging of both verum as well as synthetic Vitamin B-complex. Each package consists of 126 capsules per subject and period. Each product was tagged with the subject-number and period (period I and period II). Study-subjects were blinded by the person in charge for randomization through a sealed envelope. The allocation was in the relation of 1:1 between group A (verum in period I and synthetic Vitamin B-complex in period II) and group B (synthetic Vitamin B-complex in period I and verum in period II). The ultimate subject list was forwarded to the person in charge for randomization after the run-in phase. Method: Blood sampling: Blood (max. 20ml) was collected in a seated position from an antecubital vein. Time schedule: Run-in-phase: 3 weeks (no supplementation) Determination of inclusion criteria, nutrition advice, randomization. Phase I: 6 weeks (supplementation) Group A - natural Vitamin B-complex supplementation every day Group B - synthetic Vitamin B-complex supplementation every day Blood sampling: First day: Fasting value (basic) - Vitamin B-complex supplementation - After 1.5 hours After 4 hours After 7 hours End of first supplementation: After 6 weeks Wash-out period: 2 weeks (without supplementation) Phase II: 6 weeks (supplementation) Group A - synthetic Vitamin B-complex supplementation every day Group B - natural Vitamin B-complex supplementation every day Blood sampling: First day: Fasting value (basic) - Vitamin B-complex supplementation - After 1.5 hours After 4 hours After 7 hours End of second supplementation: After 6 weeks Wash-out period II: 6 weeks (without supplementation) Final exam - last blood sampling Drop-out-criteria: Drawback Compliance (<80% of Vitamin B-complexes) Supplementation of Vitamin B-complexes during run-in-phase or wash-out periods Primary-target parameters: Serum concentrations for vitamins B1, B2, B6, B9 and B12 Secondary-target biomarkers: Serum concentrations for Total antioxidants, total peroxides, peroxidase-activity, polyphenols and homocysteine. Biometry: Comparison of interventions in a cross-over approach descriptive and exploratory. Group comparison: Parametric and non-parametric cross-over comparison Gaussian distribution - (Kolmogorov-Smirnov-test with Lilliefors-significances, alpha =10%). Effect size: Two-sided 95%-confidence intervals Analysis: Intent-to-treat-analysis Per-protocol-analysis Full analysis set Vitamin B and Homocysteine analysis was done in a routine laboratory. Antioxidants (TAC), peroxidase-activity (EPA), peroxides (TOC) and polyphenols (PPm) were measured by the use of commercially available microtitre assays at a wavelength of 450 vs. 620 nm. In case of PPm a wavelength of 766nm was used. Implausible values will be scored as missing values. Missing values are not substituted. Presentation of results: Minimum-Median-Quartiles-Maximum-Mean-Standard deviation. Box Plots, Bar graph, tables.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy, Thiamine and Niacin Deficiency States, Pyridoxine Deficiency, Folic Acid Deficiency Anemia, Dietary, Vitamin B 12 Deficiency, Peroxidase; Defect, Polyphenols, Oxidative Stress, Homocystine; Metabolic Disorder

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Vitamin B complex (natural vs. synthetic) administered in capsules each day for 6 weeks - 2 weeks wash-out phase I (2 weeks) - cross-over 6 weeks - wash-out phase II (6 weeks)
Masking
ParticipantInvestigator
Masking Description
Masking was organized and supervised by the randomization person in charge. Group assignment was 1:1 (control vs. verum group) with identical packages for both Vitamin supplements with 126 capsules for each subject per phase. Randomization was done with sealed envelopes.
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Natural Panmol-B-Complex first, then synthetic Vitamin B-complex
Arm Type
Active Comparator
Arm Description
Participants first received a Natural Vitamin B-complex, i.e., Panmol-B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.
Arm Title
Synthetic Vitamin B-complex first, then Natural Panmol-B-Complex
Arm Type
Active Comparator
Arm Description
Participants first received a Synthetic Vitamin B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks. After a wash-out period of 2 weeks, they then received a natural Vitamin B-complex, i.e., Panmol-B-complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) daily each morning for 6 weeks.The study finished after the second wash-out period for another 6 weeks.
Intervention Type
Dietary Supplement
Intervention Name(s)
Natural Panmol-B-Complex
Intervention Description
Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg) - Synthetic Vitamin B-Complex - B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)
Intervention Type
Dietary Supplement
Intervention Name(s)
Synthetic Vitamin B-Complex
Intervention Description
Synthetic Vitamin B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85µg) - Natural Panmol-B-Complex: B1 (2.93 mg), B2 (3.98 mg), B3 (29.85 mg), B5 (10.95 mg), B6 (3.38 mg), B7 (0.108 mg), B9 (0.69 mg), B12 (8.85 µg)
Primary Outcome Measure Information:
Title
Serum Thiamine
Description
Serum Thiamine in microgram per liter Minimum: 36 Maximum: 98
Time Frame
20 weeks
Title
Serum Riboflavin
Description
Serum Riboflavin in microgram per liter Minimum: 190 Maximum: 341
Time Frame
20 weeks
Title
Serum Pyridoxine
Description
Serum Pyridoxine in microgram per liter Minimum: 3.8 Maximum: 161.8
Time Frame
20 weeks
Title
Serum Folic Acid
Description
Serum Folic acid in nanogram per liter Minimum: 2.20 Maximum: 58.10
Time Frame
20 weeks
Title
Serum Cobalamin
Description
Serum Cobalamin in picogram per liter Minimum: 159 Maximum: 1230
Time Frame
20 weeks
Secondary Outcome Measure Information:
Title
Serum Total Peroxides
Description
Serum Total peroxides in micromol per liter Minimum: 23 Maximum: 443
Time Frame
20 weeks
Title
Serum Total Antioxidant Capacity
Description
Serum total antioxidant capacity in millimole per liter Minimum: 0.31 Maximum: 2.45
Time Frame
20 weeks
Title
Serum Endogenous Peroxidase-activity
Description
Serum endogenous peroxidase-activity in milliunits per milliliter Minimum: 0.79 Maximum: 9.87
Time Frame
20 weeks
Title
Serum Polyphenols
Description
Serum Polyphenols in millimole per liter Minimum: 7.45 Maximum: 10.91
Time Frame
20 weeks
Title
Total Homocysteine
Description
Total Homocysteine in Micromole Minimum: 4.00 Maximum: 40.40
Time Frame
20 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male and female 18-65 y Healthy Exclusion Criteria: Cholesterol >240mg/dl Study inclusion in the past 2 months Pregnancy and lactation period Clinical diagnosis of chronic infections Ingestion of trace elements, vitamin- and fatty acid supplements in the past 3 months Clinical diagnosis of cardiovascular disease Clinical diagnosis of cancer Clinical diagnosis of psychotic diseases Insulin dependent diabetes Clinical diagnosis of autoimmune diseases Maldigestion/Malabsorption Veganes cuisine > 1 Beer/day
Facility Information:
Facility Name
Wonisch Willibald
City
Graz
State/Province
Styria
ZIP/Postal Code
8036
Country
Austria

12. IPD Sharing Statement

Citations:
PubMed Identifier
31915511
Citation
Lindschinger M, Tatzber F, Schimetta W, Schmid I, Lindschinger B, Cvirn G, Stanger O, Lamont E, Wonisch W. A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels. Oxid Med Cell Longev. 2019 Dec 12;2019:6082613. doi: 10.1155/2019/6082613. eCollection 2019.
Results Reference
result
PubMed Identifier
32189314
Citation
Lindschinger M, Tatzber F, Schimetta W, Schmid I, Lindschinger B, Cvirn G, Fuchs N, Markolin G, Lamont E, Wonisch W. [Bioavailability of natural versus synthetic B vitamins and their effects on metabolic processes]. MMW Fortschr Med. 2020 Mar;162(Suppl 4):17-27. doi: 10.1007/s15006-020-0230-4. Epub 2020 Mar 19. German.
Results Reference
result

Learn more about this trial

Natural Versus Synthetic Vitamin B Complexes in Human

We'll reach out to this number within 24 hrs